John Deanfield

91.7k total citations · 29 hit papers
545 papers, 58.7k citations indexed

About

John Deanfield is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, John Deanfield has authored 545 papers receiving a total of 58.7k indexed citations (citations by other indexed papers that have themselves been cited), including 317 papers in Cardiology and Cardiovascular Medicine, 142 papers in Epidemiology and 104 papers in Surgery. Recurrent topics in John Deanfield's work include Congenital Heart Disease Studies (112 papers), Cardiovascular Health and Disease Prevention (100 papers) and Blood Pressure and Hypertension Studies (60 papers). John Deanfield is often cited by papers focused on Congenital Heart Disease Studies (112 papers), Cardiovascular Health and Disease Prevention (100 papers) and Blood Pressure and Hypertension Studies (60 papers). John Deanfield collaborates with scholars based in United Kingdom, United States and Canada. John Deanfield's co-authors include David S. Celermajer, Keld E. Sørensen, Ann E. Donald, Julian Halcox, J. Robinson, Ton J. Rabelink, Ian D. Sullivan, D. J. Spiegelhalter, Dimitri Georgakopoulos and Catherine Bull and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

John Deanfield

529 papers receiving 56.8k citations

Hit Papers

Non-invasive detection of endothelial dysfunction in chil... 1981 2026 1996 2011 1992 2002 2007 2019 2023 1000 2.0k 3.0k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis
    1992 3.8k citations John Deanfield et al. profile →
  2. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery
    2002 3.8k citations John Deanfield, Patrick Vallance et al. Journal of the American College of Cardiology profile →
  3. Endothelial Function and Dysfunction
    2007 2.1k citations John Deanfield et al. Circulation profile →
  4. Atherosclerosis
    2019 2.0k citations John Deanfield et al. profile →
  5. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes
    2023 1.3k citations A. Michael Lincoff, Helen M. Colhoun et al. profile →
  6. Cigarette smoking is associated with dose-related and potentially reversible impairment of endothelium-dependent dilation in healthy young adults.
    1993 1.2k citations John Deanfield et al. Circulation profile →
  7. Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people
    2014 1.2k citations Adam Timmis, Spiros Denaxas et al. profile →
  8. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women
    1994 1.1k citations John Deanfield et al. Journal of the American College of Cardiology profile →
  9. Endothelium-dependent dilation in the systemic arteries of asymptomatic subjects relates to coronary risk factors and their interaction
    1994 1.0k citations John Deanfield et al. Journal of the American College of Cardiology profile →
  10. Treatment of Periodontitis and Endothelial Function
    2007 1.0k citations Francesco D’Aiuto, Ann E. Donald et al. profile →
  11. The Assessment of Endothelial Function
    2012 876 citations John Deanfield et al. Circulation profile →
  12. Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people
    2014 817 citations Spiros Denaxas, Chris P Gale et al. profile →
  13. Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite
    2008 811 citations David J. Webb, Stavros Loukogeorgakis et al. Hypertension profile →
  14. Passive Smoking and Impaired Endothelium-Dependent Arterial Dilatation in Healthy Young Adults
    1996 687 citations Ann E. Donald, John Deanfield et al. profile →
  15. Expert consensus and evidence-based recommendations for the assessment of flow-mediated dilation in humans
    2019 634 citations John Deanfield et al. European Heart Journal profile →
  16. Non-invasive measurement of human endothelium dependent arterial responses: accuracy and reproducibility.
    1995 596 citations John Deanfield et al. Heart profile →
  17. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension*
    2005 591 citations John Deanfield, Ann E. Donald et al. profile →
  18. International Day for the Evaluation of Abdominal Obesity (IDEA)
    2007 553 citations John Deanfield et al. Circulation profile →
  19. Mental Stress Induces Transient Endothelial Dysfunction in Humans
    2000 509 citations Ann E. Donald, John Deanfield et al. Circulation profile →
  20. MYOCARDIAL ISCHAEMIA DURING DAILY LIFE IN PATIENTS WITH STABLE ANGINA: ITS RELATION TO SYMPTOMS AND HEART RATE CHANGES
    1983 502 citations John Deanfield et al. profile →
  21. Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.
    1994 478 citations John Deanfield et al. profile →
  22. Prognosis in hypertrophic cardiomyopathy: Role of age and clinical, electrocardiographic and hemodynamic features
    1981 453 citations William J. McKenna, John Deanfield et al. profile →
  23. COVID-19 pandemic and admission rates for and management of acute coronary syndromes in England
    2020 430 citations Chris P Gale, Mamas A. Mamas et al. profile →
  24. Effects of tobacco cigarettes, e-cigarettes, and waterpipe smoking on endothelial function and clinical outcomes
    2020 243 citations John Deanfield et al. European Heart Journal profile →
  25. Semaglutide versus placebo in patients with heart failure and mildly reduced or preserved ejection fraction: a pooled analysis of the SELECT, FLOW, STEP-HFpEF, and STEP-HFpEF DM randomised trials
    2024 123 citations John Deanfield, Ildiko Lingvay et al. profile →
  26. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial
    2024 123 citations Donna H. Ryan, Ildiko Lingvay et al. profile →
  27. Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial
    2024 102 citations Helen M. Colhoun, Ildiko Lingvay et al. profile →
  28. Semaglutide and cardiovascular outcomes in patients with obesity and prevalent heart failure: a prespecified analysis of the SELECT trial
    2024 100 citations John Deanfield, Benjamin M. Scirica et al. profile →
  29. Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes
    2025 89 citations Nikolaus Marx, John Deanfield et al. profile →

Peers

John Deanfield
Comparison fields: 5 of 202
  • Cardiology and Cardiovascular Medicine 31.6k
  • Surgery 11.4k
  • Epidemiology 10.5k
  • Pulmonary and Respiratory Medicine 9.8k
  • Physiology 8.3k
Replace Philip A. Wolf with:
Philip A. Wolf United States
Mark A. Creager United States
David S. Celermajer Australia
Aaron R. Folsom United States
Martin G. Larson United States
Joseph M. Massaro United States
Tom Greene United States
Mary Cushman United States
Christodoulos Stefanadis Greece
Rory Collins United Kingdom
Philip A. Wolf United States View profile →
Citations per field, relative to John Deanfield
John Deanfield · 1×
Citations per year, relative to John Deanfield
John Deanfield · 1×

Countries citing papers authored by John Deanfield

Since Specialization
Citations

This map shows the geographic impact of John Deanfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John Deanfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John Deanfield more than expected).

Fields of papers citing papers by John Deanfield

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John Deanfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John Deanfield. The network helps show where John Deanfield may publish in the future.

Co-authorship network of co-authors of John Deanfield

This figure shows the co-authorship network connecting the top 25 collaborators of John Deanfield. A scholar is included among the top collaborators of John Deanfield based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John Deanfield. John Deanfield is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
# Work Indexed citations
1
The Effect of Semaglutide on Mortality and COVID-19–Related Deaths
2024 ·Journal of the American College of Cardiology ·Benjamin M. Scirica, A. Michael Lincoff, Ildiko Lingvay, Paweł Bogdański, Silvio Buscemi, Helen M. Colhoun, (unknown), М. В. Ежов, Søren Hardt‐Lindberg, Ole Kleist Jeppesen, (unknown), Koichi Node, (unknown), Hermann Toplak, André P. van Beek, Peter Weeke, Stephen D. Wiviott, John Deanfield, Donna H. Ryan
22
2
Management and outcomes of myocardial infarction in people with impaired kidney function in England
2023 ·BMC Nephrology ·(unknown), Patrick Bidulka, Dominic Taylor, Udaya Udayaraj, Fergus Caskey, Kate Birnie, John Deanfield, Mark de Belder, Spiros Denaxas, Clive Weston, David Adlam, Dorothea Nitsch
5
3
Prevalence of systemic inflammation in individuals with atherosclerotic cardiovascular disease: baseline characteristics from the SELECT, SOUL and FLOW phase 3 trials of semaglutide
2023 ·European Heart Journal ·Nikolaus Marx, John Deanfield, Sofia Gerward, G. Kees Hovingh, (unknown), Richard E. Pratley, (unknown), Vlado Perkovic
2
4
The Roles of Neutrophils Linking Periodontitis and Atherosclerotic Cardiovascular Diseases
2022 ·Frontiers in Immunology ·(unknown), Scott T. Chiesa, George Hajishengallis, Venizelos Papayannopoulos, John Deanfield, Francesco D’Aiuto
32
5
Integrated Polygenic Tool Substantially Enhances Coronary Artery Disease Prediction
2021 ·Circulation Genomic and Precision Medicine ·Fernando Riveros-Mckay, Michael E. Weale, Rachel Moore, Saskia Selzam, Eva Krapohl, (unknown), William A. Tarran, Peter Sørensen, Alexander S. Lachapelle, Jonathan A. Griffiths, Ayden Saffari, John Deanfield, Chris C. A. Spencer, Julia Hippisley–Cox, (unknown), Jack W. O’Sullivan, Euan A. Ashley, Vincent Plagnol, Peter Donnelly
96
6
Outcomes of COVID‐19‐positive acute coronary syndrome patients: A multisource electronic healthcare records study from England
2021 ·Journal of Internal Medicine ·Muhammad Rashid, Jianhua Wu, Adam Timmis, Nick Curzen, Sarah Clarke, Azfar Zaman, James Nolan, Ahmad Shoaib, Mohamed O. Mohamed, Mark de Belder, John Deanfield, Chris P Gale, Mamas A. Mamas
39
7
Racial differences in management and outcomes of acute myocardial infarction during COVID-19 pandemic
2021 ·Heart ·Muhammad Rashid, Adam Timmis, Tim Kinnaird, Nick Curzen, Azfar Zaman, Ahmad Shoaib, Mohamed O. Mohamed, Mark de Belder, John Deanfield, Glen P. Martin, Jianhua Wu, Chris P Gale, Mamas A. Mamas
26
8
Excess mortality in England and Wales during the first wave of the COVID-19 pandemic
2020 ·Journal of Epidemiology & Community Health ·Evangelos Kontopantelis, Mamas A. Mamas, John Deanfield, Miqdad Asaria, Tim Doran
73
9
Patient response, treatments, and mortality for acute myocardial infarction during the COVID-19 pandemic
2020 ·European Heart Journal - Quality of Care and Clinical Outcomes ·Jianhua Wu, Mamas A. Mamas, Muhammad Rashid, Clive Weston, (unknown), (unknown), Mark de Belder, John Deanfield, Chris P Gale
77
10
Impact of COVID-19 on percutaneous coronary intervention for ST-elevation myocardial infarction
2020 ·Heart ·Chun Shing Kwok, Chris P Gale, Tim Kinnaird, Nick Curzen, Peter Ludman, Evangelos Kontopantelis, Jianhua Wu, Tom Denwood, Nadeem Fazal, John Deanfield, Mark de Belder, Mamas A. Mamas
68
11
Assessing the Causal Role of Body Mass Index on Cardiovascular Health in Young Adults
2018 ·Circulation ·Kaitlin H. Wade, Scott T. Chiesa, Alun D. Hughes, Nish Chaturvedi, Marietta Charakida, Alicja Rapala, Vivek Muthurangu, Tauseef Khan, Nick Finer, Naveed Sattar, Laura D Howe, Abigail Fraser, Debbie A. Lawlor, George Davey Smith, John Deanfield, Nicholas J. Timpson
55
12
Habitual alcohol consumption is associated with lower cardiovascular stress responses – a novel explanation for the known cardiovascular benefits of alcohol?
2013 ·Stress ·Alexander Jones, (unknown), Russell Jones, (unknown), Jennifer A. Steeden, Jens C. Pruessner, Andrew M. Taylor, John Deanfield, Vivek Muthurangu
17
13
Remote Ischemic Preconditioning Protects the Brain Against Injury After Hypothermic Circulatory Arrest
2011 ·Circulation ·Hanna Jensen, Stavros Loukogeorgakis, Fredrik Yannopoulos, (unknown), Axel Petzold, Hannu Tuominen, Pasi Lepola, Raymond J. MacAllister, John Deanfield, (unknown), (unknown), Kai Kiviluoma, Vesa Anttila, Victor Tsang, Tatu Juvonen
133
14
Guidelines regarding the treatment of adult patients with congenital heart disease (new version-2010)
2010 ·UCL Discovery (University College London) ·H. Baumgärtner, (unknown), (unknown), (unknown), John Deanfield, Nazzareno Galiè, M. Gatzoulis, Christa Gohlke-Baerwolf, (unknown), Philip J. Kilner, (unknown), B. J. M. Mulder, Erwin Oechslin, (unknown), Alain Serraf, András Szatmári, E Thaulow, (unknown), Edmond Walma
1
15
Acute Blood Pressure Lowering, Vasoprotective, and Antiplatelet Properties of Dietary Nitrate via Bioconversion to Nitrite breakdown →
2008 ·Hypertension ·David J. Webb, (unknown), Stavros Loukogeorgakis, M Okorie, Zainab Aboud, Shivani Misra, (unknown), (unknown), John Deanfield, Nigel Benjamin, Raymond J. MacAllister, Adrian J. Hobbs, Amrita Ahluwalia
811
16
Percutaneous Pulmonary Valve Implantation
2008 ·Circulation ·Philipp Lurz, Louise Coats, Sachin Khambadkone, Johannes Nordmeyer, Younès Boudjemline, Silvia Schievano, Vivek Muthurangu, (unknown), (unknown), Graham Derrick, Seamus Cullen, Fiona Walker, Victor Tsang, John Deanfield, Andrew M. Taylor, Philipp Bonhoeffer
337
17
Inflammation and Endothelial Function
2005 ·Circulation ·Brian Clapp, Gideon M. Hirschfield, Clare Storry, J. Ruth Gallimore, Ray Stidwill, Mervyn Singer, John Deanfield, Raymond J. MacAllister, Mark B. Pepys, Patrick Vallance, Aroon D. Hingorani
145
18
Oral L-arginine does not improve endothelial dysfunction in children with chronic renal failure
2002 ·Kidney International ·(unknown), Mia Kattenhorn, Ann E. Donald, (unknown), Zac Varghese, K. Richard Bruckdorfer, John Deanfield, Lesley Rees
56
19
REGIONAL RIGHT VENTRICULAR-FUNCTION IN POST OPERATIVE TETRALOGY OF FALLOT - ASSESSMENT BY ENDOCARDIAL MAPPING AND PHASE IMAGING OF KRYPTON-81M RADIONUCLIDE ANGIOGRAMS
1982 ·UCL Discovery (University College London) ·John Deanfield, D. Sugrue, William J. McKenna, Ethan M. Rowland, K A Hallidie-Smith, P Lavender, C M Oakley
3
20
FACTORS PREDICTING VENTRICULAR ARRHYTHMIA AFTER CORRECTION OF TETRALOGY OF FALLOT
1981 ·UCL Discovery (University College London) ·John Deanfield, William J. McKenna, (unknown), (unknown), P Lavender, (unknown)
1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Philip A. Wolf Breakdown of academic impact, for papers by Mark A. Creager Breakdown of academic impact, for papers by David S. Celermajer Breakdown of academic impact, for papers by Aaron R. Folsom Breakdown of academic impact, for papers by Martin G. Larson Breakdown of academic impact, for papers by Joseph M. Massaro Breakdown of academic impact, for papers by Tom Greene Breakdown of academic impact, for papers by Mary Cushman Breakdown of academic impact, for papers by Christodoulos Stefanadis Breakdown of academic impact, for papers by Rory Collins
Rankless by CCL
2026